Perry Nicole D 4
4 · Apellis Pharmaceuticals, Inc. · Filed May 4, 2021
Insider Transaction Report
Form 4
Perry Nicole D
Vice President - Finance
Transactions
- Exercise/Conversion
Common Stock
2021-05-03$3.76/sh+1,000$3,760→ 5,847 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-03−1,000→ 9,161 totalExercise: $3.76Exp: 2025-07-31→ Common Stock (1,000 underlying) - Sale
Common Stock
2021-05-03$50.73/sh−1,000$50,730→ 4,847 total
Footnotes (1)
- [F1]This option was granted on July 31, 2015 and is fully vested.